510(k) device
Zoll E Series
Zoll Medical Corporation, World Wide Headquarters · Automated External Defibrillators (Non-Wearable) (MKJ, Class III) · First FDA decision Apr 26, 2007, newest Jan 16, 2015Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
510(k) pathway
Device trials
16
Naming "E Series"
MAUDE reports
3,198
Brand "E Series", since 2015
PubMed studies
617
Mentioning "E Series"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Zoll E Series
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- ZOLL E SERIES510(k)
K133239 · Decided Jan 16, 2015 · 452 days after receipt
Device type: Automated External Defibrillators (Non-Wearable) (MKJ) · Cardiology
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Automatic External DefibrillatorsLocal determinationIn effectL33690CGS Administrators, LLCUpdated Feb 13, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "E Series", any status and sponsor, newest update first.
University of AleppoAcademic, hospital or other
NCT07897864 · 40 participants (planned) · Start Jan 15, 2027 · Primary completion Oct 15, 2028
Device: Conventional Labial Fixed Orthodontic Appliance; 3D-BOT Using E-WIRE Archwires · For: Mild-to-Moderate Mandibular Anterior Crowding
Sites: Aleppo, Syria
15 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "E Series", and for the whole product code for context.
This brand
3,198 reports: 3,119 malfunction, 56 injury, 21 death
Whole product code MKJ
182,946 reports: 179,314 malfunction, 1,608 injury, 1,965 death
Newest reports for this brand
3005248192-2026-00096 · Received Oct 19, 2026 · Event dated Sep 1, 2026
Device type: Real Time Nucleic Acid Amplification System (OOI)
Device problem as coded: Improper or Incorrect Procedure or Method; Fumes or Vapors
Patient problem as coded: Eye Irritation
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "E Series"[tiab]. The summary above synthesizes these.
- Lipid Mediators in Inflammation.
Bennett M, Gilroy DW · Microbiol Spectr · 2016Review
- Biosynthesis of prostaglandins.
Flower RJ · Ciba Found Symp · 1978
- Resolvin E1 improves efferocytosis and rescues severe aplastic anemia in mice.
Grazda R, Seyfried AN, Maddipati KR, et al. · Cell Death Dis · 2024Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
- n-3 Fatty acids and asthma.
Kumar A, Mastana SS, Lindley MR · Nutr Res Rev · 2016Review
- Pharmacology of prostaglandins.
Main IH · Postgrad Med J · 1988
- Chronobiology of blood pressure.
Delea CS · Nephron · 1979
- Angiogenesis: an update.
Díaz-Flores L, Gutiérrez R, Varela H · Histol Histopathol · 1994Research Support, Non-U.S. Gov't, Review
- Prolonged experimental sleep disturbance affects the inflammatory resolution pathways in healthy humans.
Engert LC, Mullington JM, Haack M · Brain Behav Immun · 2023Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution.
Libreros S, Shay AE, Nshimiyimana R, et al. · Front Immunol · 2020Research Support, N.I.H., Extramural
- E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN, Libreros S, Nshimiyimana R · Semin Immunol · 2022Review, Research Support, N.I.H., Extramural
- D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.
Ganesan R, Henkels KM, Shah K, et al. · FASEB J · 2020Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MKJ.
- AED 3 Defibrillator with Uni-PadzZOLL Medical Corporation · PMA 2026
- X Series®ZOLL Medical Corporation · PMA 2025
- HeartStart FRx Defibrillator (861304)Philips Medical Systems · PMA 2024
- Philips HeartStart FR3 DefibrillatorPhilips Medical Systems, Inc. · PMA 2020
- LIFEPAK 20e defibrillator/monitorPhysio-Control, Inc. · PMA 2019
- Lifeline/ReviveR DDU-100Defibtech, LLC · PMA 2026
- AED Plus, AED 3, X Series, R Series, Propaq MD, AED Pro, AED 3 BLSZOLL Medical Corporation · PMA 2025
- Defibtech Automated External Defibrillator (AED) SystemsDefibtech, LLC · PMA 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.